Zeff The Great wrote a post · Mar 8, 2024 12:26

Genting strikes gold in TauRx

After years of researches and studies , finally TauRx released the full results and presentation of Phase 3 clinical studies of the flagship medicine named HMTM .

$GENTING (3182.MY)$ is having a 20% stake in TauRx , in which it is currently not making profits as the principal product HMTM is still under development and yet to be commercialized.

With the data released from the clinical trials , it is likely that TauRx’s HMTM will get the approvals from authority of key market such as UK and US.

This is considered as “extra bonus” to Genting’s asset value , other than the current businesses. Maybank Investment Bank assigned a target price of RM 9.40 , if the product HMTM is approved and commercialized in the future

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

295K Views

Comment

SpyderCall : Might see a breakout of long-term resistance in this ticker. It is just below resistance now. Watch out for a rejection, though.

Report
Reply

Cancel Reply
102932551 : Wait for the harvest...

Report
Reply

Cancel Reply

Zeff The Great

▶️ Chief Trainer @Sharix.my ▶️ grow portfolio from RM 10k to RM 1 mil in 5 yrs ▶️ follow my FB [Zeff的宏财伟略]

13K

Followers

Following

27K

Visitors